Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft
Clinical trial NCT03187756 · TERMINATED
Trial details
- NCT number
- NCT03187756
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2018-12-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.